Atlas Trials

The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients

Clinical trial NCT02711410 · COMPLETED

Trial details

NCT number
NCT02711410
Sponsor
National Cerebral and Cardiovascular Center, Japan
Status
COMPLETED
Study type
OBSERVATIONAL
Platelet Aggregation Inhibitors
Start date
2009-10-01
Primary completion
2014-04-01
Enrollment
518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.